Rosa David J. - Feb 7, 2024 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
President
Signature
By: Donna Spinola For: Rosa, David J
Stock symbol
ISRG
Transactions as of
Feb 7, 2024
Transactions value $
-$24,042,501
Form type
4
Date filed
2/8/2024, 02:06 PM
Previous filing
Dec 14, 2023
Next filing
Feb 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $1.31M +22.1K +14.3% $59.23 176K Feb 7, 2024 Direct F1
transaction ISRG Common Stock Sale -$5.02M -12.9K -7.32% $389.29 163K Feb 7, 2024 Direct F1, F2
transaction ISRG Common Stock Options Exercise $1.26M +22.1K +13.49% $57.11 185K Feb 7, 2024 Direct F1
transaction ISRG Common Stock Sale -$5M -12.8K -6.92% $389.30 173K Feb 7, 2024 Direct F1, F3
transaction ISRG Common Stock Options Exercise $1.43M +28.1K +16.29% $51.02 201K Feb 7, 2024 Direct F1
transaction ISRG Common Stock Sale -$6.29M -16.2K -8.05% $389.23 185K Feb 7, 2024 Direct F1, F4
transaction ISRG Common Stock Options Exercise $1.99M +40.5K +21.94% $49.09 225K Feb 7, 2024 Direct F1
transaction ISRG Common Stock Sale -$9M -23.1K -10.27% $389.28 202K Feb 7, 2024 Direct F1, F5
transaction ISRG Common Stock Options Exercise $1.39M +28.1K +13.93% $49.34 230K Feb 7, 2024 Direct F1
transaction ISRG Common Stock Sale -$6.11M -15.7K -6.82% $389.29 214K Feb 7, 2024 Direct F1, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -40.5K -100% $0.00* 0 Feb 7, 2024 Common Stock 40.5K $49.09 Direct F1, F7
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -28.1K -100% $0.00* 0 Feb 7, 2024 Common Stock 28.1K $49.34 Direct F1, F7
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -28.1K -100% $0.00* 0 Feb 7, 2024 Common Stock 28.1K $51.02 Direct F1, F8
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -22.1K -100% $0.00* 0 Feb 7, 2024 Common Stock 22.1K $57.11 Direct F1, F7
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -22.1K -100% $0.00* 0 Feb 7, 2024 Common Stock 22.1K $59.23 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2025.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57 as follows: 1,000 shares sold at $386.61 to $387.54; 2,050 shares sold at $387.70 to $388.67; 6,109 shares sold at $388.80 to $389.76; 3,201 shares sold at $389.84 to $390.61; and 540 shares sold at $390.91 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57 as follows: 1,100 shares sold at $386.61 to $387.54; 1,900 shares sold at $387.70 to $388.67; 5,974 shares sold at $388.80 to $389.75; 3,526 shares sold at $389.84 to $390.79; and 340 shares sold at $390.96 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57 as follows: 1,712 shares sold at $386.61 to $387.37; 2,350 shares sold at $387.70 to $388.42; 7,354 shares sold at $388.80 to $389.77; 4,094 shares sold at $389.84 to $390.73; and 640 shares sold at $390.91 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $392.00 as follows: 2,057 shares sold at $386.61 to $387.37; 3,377 shares sold at $387.70 to $388.69; 10,942 shares sold at $388.77 to $389.77; 5,904 shares sold at $389.79 to $390.79; 740 shares sold at $390.91 to $391.57; and 100 shares sold at $392.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F6 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57as follows: 1,300 shares sold at $386.61 to $387.54; 2,400 shares sold at $387.70 to $388.67; 7,622 shares sold at $388.77 to $389.75; 3,938 shares sold at $389.84 to $390.79; and 440 shares sold at $390.96 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F7 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
F8 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.